Published Erratum
doi: 10.2147/TCRM.S384532.
eCollection 2022.
Erratum: Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]
- PMID: 35958346
- PMCID: PMC9357556
- DOI: 10.2147/TCRM.S384532
Item in Clipboard
Published Erratum
Erratum: Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]
Ther Clin Risk Manag.
.
Abstract
[This corrects the article DOI: 10.2147/TCRM.S266031.].
© 2022 Waheed et al.
Erratum for
-
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review.Ther Clin Risk Manag. 2022 Jul 12;18:699-719. doi: 10.2147/TCRM.S266031. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 35855752 Free PMC article. Review.
Similar articles
-
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review.Ther Clin Risk Manag. 2022 Jul 12;18:699-719. doi: 10.2147/TCRM.S266031. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 35855752 Free PMC article. Review.
-
Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis.J Neuromuscul Dis. 2021;8(2):287-294. doi: 10.3233/JND-200584. J Neuromuscul Dis. 2021. PMID: 33325394 Free PMC article.
-
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.Neurology. 2021 Jan 26;96(4):e610-e618. doi: 10.1212/WNL.0000000000011207. Epub 2020 Nov 23. Neurology. 2021. PMID: 33229455 Free PMC article. Clinical Trial.
-
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.Muscle Nerve. 2021 Dec;64(6):662-669. doi: 10.1002/mus.27422. Epub 2021 Oct 14. Muscle Nerve. 2021. PMID: 34590717 Clinical Trial.
-
Eculizumab treatment for myasthenia gravis subgroups: 2021 update.J Neuroimmunol. 2022 Jan 15;362:577767. doi: 10.1016/j.jneuroim.2021.577767. Epub 2021 Nov 18. J Neuroimmunol. 2022. PMID: 34823117 Review.
Publication types
LinkOut - more resources
Full Text Sources
